Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana C Anderson

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Cancer Immunology Research|May 6, 2014
Tim-3: an emerging target in the cancer immunotherapy landscapeAna C Anderson
Journal of Immunology (Baltimore, Md. : 1950)|January 16, 2024
Discovery of TIM-3: Beyond a Th1 RegulatorAna C Anderson
Cell Research|January 19, 2024
Decoding T cell state-specific regulomes in cancerGiulia Escobar, Ana C Anderson
Nature Immunology|July 30, 2020
NRP1 cripples immunological memoryNandini Acharya, Ana C Anderson
Immunometabolism (Cobham, Surrey)|November 7, 2022
Steroid hormone regulation of immune responses in cancerAna C Anderson, Nandini Acharya
Cancer Immunology Research|February 3, 2019
Revolutionizing Cancer Immunology: The Power of Next-Generation Sequencing TechnologiesMeromit Singer, Ana C Anderson
Science Immunology|September 5, 2025
Loss-of-function mutations ensure that response to immune checkpoint therapy is NOD2 be deniedAna C Anderson, Manu Rangachari
Immunity|October 17, 2019
New Clones on the BlockNandini Acharya, Ana C Anderson
The Journal of Experimental Medicine|December 6, 2003
Expression of self-antigen in the thymus: a little goes a long wayAna C Anderson, Vijay K Kuchroo
Current Opinion in Immunology|October 3, 2006
TIM-3 in autoimmunityAna C Anderson, David E Anderson
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Cancer Immunology Research|May 6, 2014
Tim-3: an emerging target in the cancer immunotherapy landscapeAna C Anderson
Journal of Immunology (Baltimore, Md. : 1950)|January 16, 2024
Discovery of TIM-3: Beyond a Th1 RegulatorAna C Anderson
Cell Research|January 19, 2024
Decoding T cell state-specific regulomes in cancerGiulia Escobar, Ana C Anderson
Nature Immunology|July 30, 2020
NRP1 cripples immunological memoryNandini Acharya, Ana C Anderson
Immunometabolism (Cobham, Surrey)|November 7, 2022
Steroid hormone regulation of immune responses in cancerAna C Anderson, Nandini Acharya
Cancer Immunology Research|February 3, 2019
Revolutionizing Cancer Immunology: The Power of Next-Generation Sequencing TechnologiesMeromit Singer, Ana C Anderson
Science Immunology|September 5, 2025
Loss-of-function mutations ensure that response to immune checkpoint therapy is NOD2 be deniedAna C Anderson, Manu Rangachari
Immunity|October 17, 2019
New Clones on the BlockNandini Acharya, Ana C Anderson
The Journal of Experimental Medicine|December 6, 2003
Expression of self-antigen in the thymus: a little goes a long wayAna C Anderson, Vijay K Kuchroo
Current Opinion in Immunology|October 3, 2006
TIM-3 in autoimmunityAna C Anderson, David E Anderson
Pageof 11